Secondary End Points
At the 6-month follow-up, there were no statistically significant
changes in ABI measurements compared with baseline
in either the OMC and SE treatment group, whereas the
resting ABI improved by 0.290.33 in the ST group
(P0.0001; Table 3). For COT, both SE and ST demonstrated
significantly greater improvement compared with
OMC, but no significant difference was observed between
ST and SE participants. Patients assigned to both SE and
ST had greater increases in community-based step activity
than OMC participants, but this was not statistically
significant (Table 3).